Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Disease Characteristics and Treatment Patterns of Patients With Sickle Cell Disease in Globin Research Network for Data and Discovery (GRNDaD) Registry

NCT06662812 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT06662812
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06662812 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Disease Characteristics and Treatment Patterns of Patients With Sickle Cell Disease in Globin Research Network for Data and Discovery (GRNDaD) Registry
Lead sponsor
Novartis
Phase
Observational
Overall status
Completed
Start date
October 6, 2021
Completion date
December 1, 2023
Enrollment
1,665 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease